HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: Prevalence, estimated incidence and genetic diversity

Journal of Clinical Virology

Volumn 31, Issue 3, 2004, Pages 221-226

  Teixeira, Sylvia Lopes Maia ^a   Bastos, Francisco Inácio ^a   Telles, Paulo Roberto ^b   Hacker, Mariana A ^a   Brigido, Luis F ^c   Oliveira, Carmem Aparecida De F ^c   Bongertz, Vera ^a   Morgado, Mariza Gonçalves ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

env and gag subtypes; HIV 1; IDU; Incidence; Prevalence; Recombination

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; BLOOD DONOR; BRAZIL; CLINICAL ARTICLE; DRUG USE; ENVELOPE GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; INTRAVENOUS DRUG ABUSE; MALE; MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; T LYMPHOCYTE; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS TITRATION;

ADULT; BRAZIL; DNA, VIRAL; FEMALE; GENES, ENV; GENES, GAG; HETERODUPLEX ANALYSIS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RECOMBINATION, GENETIC; SUBSTANCE ABUSE, INTRAVENOUS; VARIATION (GENETICS);

EID: 4744362775     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.03.016     Document Type: Article

References (46)

1. AIDS Epidemiological Bulletin. CN DST/AIDS (April-December 2002). Brazilian Ministry of Health, December 2002 [in Portuguese].
2. Andrade TM, Dourado MI, Farias AH, et al. HIV infection prevalence and harm reductions among injection drug users in Salvador-Bahia. In: The contribution of multicentric studies to HIV/AIDS epidemic among IDU in Brazil: 10 years of research and harm reduction. Série Avaliação 8, Ministry of Health, Brazil, 2001. p. 95-114 [in Portuguese].
3. Bastos F.I., Lowndes C.M., Derrico M., et al. Sexual behavior and infections among patients attending drug treatment centres in Rio de Janeiro, Brazil. Int. J. STD AIDS. 11:2000;383-392
4. Bastos FI, Telles PR, Hacker M. A decade of research about injection drug users & HIV/AIDS in Rio de Janeiro. Part I. Going to an epidemic under control? In: The contribution of multicentric studies to HIV/AIDS epidemic among IDU in Brazil: 10 years of research and harm reduction. Série Avaliação 8, Ministry of Health, Brazil, 2001. p. 49-78 [in Portuguese].
5. Bastos F.I., Pina M.F., Szwarcwald C.L. The social geography of HIV/AIDS among injection drug users in Brazil. Int. J. Drug Policy. 13:2002;137-144
6. Bobkov A., Kazennova E., Selimova L., et al. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: identification of subtype A, subtype B, and novel gagA/envB recombinants. AIDS Res. Hum. Retroviruses. 14:1998;669-676
7. Bongertz V., Ouverney E.P., Teixeira S.L.M., et al. Higher anti-HIV-1 antibody titers in injection drug users compared to sexually infected individuals. Mem. Inst. Oswaldo Cruz. 98:2003;209-212
8. Brindeiro R.M., Diaz R.S., Sabino E.C., et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS. 17:2003;1063-1069
9. Cham F., Heyndrickx L., Janssens W., et al. Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments. AIDS Res. Hum. Retroviruses. 16:2000;1503-1505
10. Cornelissen M., Kampinga G., Zorgdrager F., et al. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. J. Virol. 70:1996;8209-8212
11. Couto-Fernandez J.C., Morgado M.G., Bongertz V., et al. HIV-1 subtyping in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics. J. Acquir. Immune Defic. Syndr. 22:1999;288-293
12. Delwart E.L., Shpaer E.G., Louwagie J., et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 262:1993;1257-1261
13. Delwart EL, Herring B, Learn Jr GH, et al. Heteroduplex mobility analysis HIV-1 env subtyping kit. Protocol version 3, NIH AIDS Research and Reference Program, 1995.
14. Esparza J., Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? Lancet. 355:2000;2061-2066
15. Gao F., Morrison S.G., Robertson D.L., et al. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J. Virol. 70:1996;1651-1667
16. Guimarães M.L., Bastos F.I., Telles P.R., et al. Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II. J. Clin. Virol. 21:2001;143-151
17. Guimaraes M.L., dos Santos Moreira A., Loureiro R., et al. High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions. AIDS Res. Hum. Retroviruses. 18:2002;1261-1269
18. Hacker MA, Friedman SR, Telles PR, et al. The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil (A report from the WHO Drug Injection Study Phase II). Substance Use Misuse 2004, in press.
19. Heyndrickx L., Janssens W., Zekeng L., et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J. Virol. 74:2000;363-370
20. Janini L.M., Tanuri A., Schechter M., et al. Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J. Infect. Dis. 177:1998;227-231
21. Janssen R.S., Satten G.A., Stramer S.L., et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. J. Am. Med. Assoc. 280:1998;42-48
22. Luo C.C., Tian C., Hu D.J., et al. HIV-1 subtype C in China. Lancet. 345:1995;1051-1052
23. Mesquita F., Kral A., Reingold A., et al. Trends of HIV infection among injection drug users in Brazil in the 1990s: the impact of changes in patterns of drug use. J. AIDS. 28:2001;298-302
24. Morgado M.G., Guimarães M.L., Gripp C.B.G., et al. Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. J. Acquir. Immune Defic. Syndr. Hum. Retroviruses. 18:1998;488-494
25. Morgado M., Guimaraes M., Galvao-Castro B. HIV-1 polymorphism: a challenge for vaccine development. A review. Mem. Inst. Oswaldo Cruz. 97:2002;143-150
26. Nguyen L., Hu D.J., Choopanya K., et al. Genetic analysis of incident HIV-1 strains among injection drug users in Bangkok: evidence for multiple transmission clusters during a period of high incidence. J. AIDS. 30:2002;248-256
27. Oelrichs R.B., Shrestha I.L., Anderson D.A., et al. The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Katmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J. Virol. 74:2000;1149-1157
28. Pechansky F., von Diemen L., Kessler F., et al. Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil. J. Urban Health. 80:2003;115-126
29. Ramos A., Tanuri A., Schechter M., et al. Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. Emerg. Infect. Dis. 5:1999;65-74
30. Rawal B.D., Degula A., Lebedeva L., et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J. Acquir. Immune Defic. Syndr. 33:2003;349-355
31. Rossini M.A.A., Diaz R.S., Caseiro M., et al. HIV-1 subtypes among intravenous drug users from two neighboring cities in São Paulo State, Brazil. Braz. J. Med. Biol. Res. 34:2001;45-47
32. Sabino E.C., Shpaer E.G., Morgado M.G., et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J. Virol. 68:1994;6340-6346
33. Sabino E.C., Diaz R.S., Brígido L.F., et al. Distribution of HIV-1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil. AIDS. 10:1996;1579-1584
34. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989. p. 458.
35. Saraswathy T.S., Ng K.P., Sinniah M. Human immunodeficiency virus type 1 among Malaysian intravenous drug users. Southeast Asian J. Trop. Med. Public Health. 31:2000;283-286
36. Subbarao S., Vanichseni S., Hu D.J., et al. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res. Hum. Retroviruses. 16:2000;699-707
37. Tatt I.D., Barlow K.L., Clewley J.P. A gag gene heteroduplex mobility assay for subtyping HIV-1. J. Virol. Methods. 87:2000;41-51
38. Telles P.R., Bastos F.I., Guydish J., et al. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS. 11:1997;S35-S42
39. Thomson M.M., Delgado E., Manjon N., et al. HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS. 15:2001;509-516
40. Turchi M.D., Diaz R.S., Martelli C.M., et al. Genetic diversity and HIV-1 incidence estimation among cocaine users in Sao Paulo, Brazil. J. Acquir. Immune Defic. Syndr. 30:2002;527-532
41. Vanichseni S., Kitayaporn D., Mastro T.D., et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS. 15:2001;397-405
42. Wasi C., Herring B., Raktham S., et al. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS. 9:1995;843-849
43. Weniger B.G., Takebe Y., Ou C.Y., et al. The molecular epidemiology of HIV in Asia. AIDS. 8:1994;S13-28
44. WHO National Network for HIV Isolation and Characterization. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994;10:1327-43.
45. Yu X.F., Chen J., Shao Y., et al. Two subtypes of HIV-1 among injection-drug users in southern China. Lancet. 351:1998;1250
46. Yu X.F., Chen J., Shao Y., et al. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J. Acquir. Immune Defic. Syndr. 22:1999;180-188